This is a preview of subscription content, log in via an institution to check access.
Notes
Consolidated Health Economic Evaluation Reporting Standards
Reference
Kemmak AR, et al. Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review. Clinical Drug Investigation : 23 Jun 2020. Available from: URL: https://doi.org/10.1007/s40261-020-00940-4
Rights and permissions
About this article
Cite this article
Rivaroxaban good choice for prevention of venous thromboembolism. PharmacoEcon Outcomes News 857, 25 (2020). https://doi.org/10.1007/s40274-020-6962-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6962-7